Journal Article Preprint Epublish
PubMed: 41959244 DOI: 10.1101/2025.08.11.669754
A population-scale atlas of blood and tissue in lupus nephritis.
bioRxiv
Authors: Nicholas W Sugiarto, Siddarth Gurajala, Michelle Curtis, Thomas M Eisenhaure, Arnon Arazi, Andrea Fava, Qian Xiao, Joseph Mears, Brad Rovin, Celine C Berthier, Yu Zhao, Peter M Izmirly, Jennifer L Barnas, Paul J Hoover, Michael Peters, Raktima Raychowdhury, Alice Horisberger, Saori Sakaue, Richard A Furie, H Michael Belmont, David A Hildeman, E Steve Woodle, Maria Dall'Era, Chaim Putterman, Diane L Kamen, Maureen A McMahon, Jennifer Grossman, Kenneth C Kalunian, Jeffrey B Hodgin, Fernanda Payan-Schober, William Apruzzese, Harris Perlman, Carla M Cuda, David Wofsy, Joel M Guthridge, Jennifer H Anolik, Judith A James, Deepak A Rao, Anne Davidson, Michelle A Petri, Jill P Buyon, Nir Hacohen, Betty Diamond, Soumya Raychaudhuri
Abstract
Lupus nephritis (LN), a severe manifestation of Systemic Lupus Erythematosus (SLE), is a heterogeneous disease driven by diverse immune and tissue cell types. We obtained 538K single-cell and 140K single-nuclear profiles from kidney biopsies of 155 LN patients and 30 pre-implantation transplant biopsy controls, along with 325K single-cell blood profiles overlapping many of these patients. We identified key tissue cell types and cell states, and immune cell states; we were able to determine cell states that were tissue specific, and those that were present in the blood. We observed that LN pathological features are significantly associated with cell states using differential gene expression and Covarying Neighborhood Analysis (CNA). These analyses revealed broad changes in cell states associated with irreversible chronic tissue damage. After controlling for the effects of ongoing tissue damage, we observed that expansion of key glomerular and Scar Associated Macrophages (SAMs) populations tracked with increasing inflammatory disease activity. SAMs appear to drive LN fibrosis and, in active disease, infiltrate the glomeruli more than other myeloid cells. These observations strongly support that therapeutic targeting of myeloid populations may offer an as-of-yet unproven strategy to prevent renal inflammation and ongoing kidney damage in LN.
MeSH
Cells, Genes, Blood, Lupus Nephritis, Kidney, Biopsy, Tissues, Nephritis